Israel - Ibrani - Ministry of Health

abic marketing ltd, israel - enalapril maleate; lercanidipine hydrochloride - טבליות מצופות פילם - lercanidipine hydrochloride 10 mg; enalapril maleate 20 mg - enalapril and lercanidipine

Israel - Ibrani - Ministry of Health

abic marketing ltd, israel - enalapril maleate; lercanidipine hydrochloride - טבליות מצופות פילם - lercanidipine hydrochloride 10 mg; enalapril maleate 20 mg - enalapril and lercanidipine

Israel - Ibrani - Ministry of Health

teva pharmaceutical indust.ltd - benazepril hydrochloride 10 mg - tablets - benazepril - antihypertensive. treatment of congestive heart failure.

Israel - Ibrani - Ministry of Health

teva pharmaceutical indust.ltd - benazepril hydrochloride 20 mg - tablets - benazepril - antihypertensive. treatment of congestive heart failure.

Israel - Ibrani - Ministry of Health

teva pharmaceutical indust.ltd - benazepril hydrochloride 5 mg - tablets - benazepril - antihypertensive. treatment of congestive heart failure.

Israel - Ibrani - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

Israel - Ibrani - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

Israel - Ibrani - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

Israel - Ibrani - Ministry of Health

rafa laboratories ltd - phenoxybenzamine hydrochloride - קפסולות - phenoxybenzamine hydrochloride 10 mg - phenoxybenzamine - phenoxybenzamine - pheochromocytoma, benign prostatic hypertrophy.